Literature DB >> 11804040

G protein-coupled receptors: dominant players in cell-cell communication.

Joël Bockaert1, Sylvie Claeysen, Carine Bécamel, Sylvie Pinloche, Aline Dumuis.   

Abstract

The G protein-coupled receptors (GPCRs) are the most numerous and the most diverse type of receptors (1-5% of the complete invertebrate and vertebrate genomes). They transduce messages as different as odorants, nucleotides, nucleosides, peptides, lipids, and proteins. There are at least eight families of GPCRs that show no sequence similarities and that use different domains to bind ligands and activate a similar set of G proteins. Homo- and heterodimerization of GPCRs seem to be the rule, and in some cases an absolute requirement, for activation. There are about 100 orphan GPCRs in the human genome which will be used to find new message molecules. Mutations of GPCRs are responsible for a wide range of genetic diseases. The importance of GPCRs in physiological processes is illustrated by the fact that they are the target of the majority of therapeutical drugs and drugs of abuse.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11804040     DOI: 10.1016/s0074-7696(01)12004-8

Source DB:  PubMed          Journal:  Int Rev Cytol        ISSN: 0074-7696


  14 in total

1.  Post-translational modifications of the serotonin type 4 receptor heterologously expressed in mouse rod cells.

Authors:  David Salom; Benlian Wang; Zhiqian Dong; Wenyu Sun; Pius Padayatti; Steven Jordan; John A Salon; Krzysztof Palczewski
Journal:  Biochemistry       Date:  2011-12-20       Impact factor: 3.162

2.  Asymmetric conformational changes in a GPCR dimer controlled by G-proteins.

Authors:  Marjorie Damian; Aimée Martin; Danielle Mesnier; Jean-Philippe Pin; Jean-Louis Banères
Journal:  EMBO J       Date:  2006-11-30       Impact factor: 11.598

3.  Common structural requirements for heptahelical domain function in class A and class C G protein-coupled receptors.

Authors:  Virginie Binet; Béatrice Duthey; Jennifer Lecaillon; Claire Vol; Julie Quoyer; Gilles Labesse; Jean-Philippe Pin; Laurent Prézeau
Journal:  J Biol Chem       Date:  2007-02-19       Impact factor: 5.157

Review 4.  Vertebrate membrane proteins: structure, function, and insights from biophysical approaches.

Authors:  Daniel J Müller; Nan Wu; Krzysztof Palczewski
Journal:  Pharmacol Rev       Date:  2008-03-05       Impact factor: 25.468

5.  Engineering a G protein-coupled receptor for structural studies: stabilization of the BLT1 receptor ground state.

Authors:  Aimée Martin; Marjorie Damian; Michel Laguerre; Joseph Parello; Bernard Pucci; Laurence Serre; Sophie Mary; Jacky Marie; Jean-Louis Banères
Journal:  Protein Sci       Date:  2009-04       Impact factor: 6.725

6.  G alpha12 is targeted to the mitochondria and affects mitochondrial morphology and motility.

Authors:  Alexandra V Andreeva; Mikhail A Kutuzov; Tatyana A Voyno-Yasenetskaya
Journal:  FASEB J       Date:  2008-03-26       Impact factor: 5.191

7.  TNFAIP8: a new effector for Galpha(i) coupling to reduce cell death and induce cell transformation.

Authors:  Benoit Laliberté; Ariel M Wilson; Houman Nafisi; Helen Mao; Yi Yuen Zhou; Mireille Daigle; Paul R Albert
Journal:  J Cell Physiol       Date:  2010-11       Impact factor: 6.384

Review 8.  The crystallographic model of rhodopsin and its use in studies of other G protein-coupled receptors.

Authors:  Slawomir Filipek; David C Teller; Krzysztof Palczewski; Ronald Stenkamp
Journal:  Annu Rev Biophys Biomol Struct       Date:  2003-02-05

9.  G protein activation by the leukotriene B4 receptor dimer. Evidence for an absence of trans-activation.

Authors:  Marjorie Damian; Sophie Mary; Aimée Martin; Jean-Philippe Pin; Jean-Louis Banères
Journal:  J Biol Chem       Date:  2008-05-19       Impact factor: 5.157

10.  Heterodimerization of V1a and V2 vasopressin receptors determines the interaction with beta-arrestin and their trafficking patterns.

Authors:  Sonia Terrillon; Claude Barberis; Michel Bouvier
Journal:  Proc Natl Acad Sci U S A       Date:  2004-02-02       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.